Archives
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis
AAP: Disparities Seen in Infant Mortality Rate for Congenital Heart Disease
From 2005 to 2019, significant decreases in mortality seen for White, but not Black, infants
AAP: Breastfeeding During Birth Hospitalization Lowers Risk for Childhood Asthma
Lower asthma risk seen for first feed with breast milk and exclusivity of breastfeeding
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
Specific antibodies against three tumor antigens identified as promising diagnostic biomarkers for early-stage melanomas
ASTRO: Hypofractionated Radiation Therapy Safe After Breast Reconstruction
Hypofractionated radiation therapy noninferior to 25-fraction conventional course for patients undergoing breast reconstruction
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
Findings seen for patients with breast cancer starting a high/moderate emetogenic chemotherapy regimen
AAP: Low Vitamin D Linked to Slower Fracture Healing in Pediatric Patients
Slower clinical and radiographic healing seen for pediatric patients with lower-extremity fracture and surgical management
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
Alternative treatments came at significantly higher costs for both payers, patients
Event-Free Survival Extended With Long-Term Finerenone in Heart Failure
Long-term finerenone extends event-free survival up to three years for heart failure with mildly reduced or preserved ejection fraction
Home-Based Phototherapy as Effective as Office-Based for Psoriasis
For plaque or guttate psoriasis, home-based phototherapy noninferior to office-based phototherapy for PGA and DLQI
